Recognition of non-operating expenses
CellSource Co.,Ltd. (the filing company)
Investment in an Investment Partnership
Loss on the operation of an investment partnership
¥11 million (non-operating expenses)
Interim consolidated accounting period of the fiscal year ending October 2026 (1 November 2025 to 30 April 2026)
Reflected in the Summary of Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending October 2026 [Japanese GAAP] (Consolidated), released today
| Item | Details |
|---|---|
| Event name | Recognition of non-operating expenses |
| Date of occurrence | Recorded in the interim consolidated accounting period of the fiscal year ending October 2026 (1 November 2025 to 30 April 2026) |
| Subject Entity | CellSource Co.,Ltd. (the filing company) |
| Target Locations / Products | Investment in an Investment Partnership |
| Cause | Loss on the operation of an investment partnership |
| Amount of Impact on Business Performance | ¥11 million (non-operating expenses) |
| Accounting period in which recognized | Interim consolidated accounting period of the fiscal year ending October 2026 (1 November 2025 to 30 April 2026) |
| Impact on Earnings Forecast | Reflected in the Summary of Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending October 2026 [Japanese GAAP] (Consolidated), released today |
Items this document does not state (17)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Based on the financial statements received concerning the investment partnership investment, a loss on the operation of the investment partnership was recognized.